A Phase II Trial of Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
NOT ENROLLING
Trial ID:
NCT03482102 Protocol # :
17-517
Conditions
Hepatocellular Carcinoma
Biliary Tract Cancer
Phase
II
Disease Sites
Liver
Principal Investigator
Hong, Theodore, S.
Site Investigator
Meyerhardt, Jeffrey
Site Research Nurses
Delrosso, Alexandria, P.
Fitton, Lindsay, Anne
Johnston, Joanna, L.
Lynch, Patricia
Meurer, Jessica, Ann
Newbert, Gordon, E.
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #17-517
17-517